| Value | ₹5.22 Cr |
|---|---|
| Execution period | 60 months |
NSE filing, NSE: CHANDAN. Summary written from the filing by ALFA Finder's alert engine.
Chandan Healthcare Ltd: key numbers
- Share price
- ₹224.20
- Market cap
- ₹576.2 Cr
- Revenue (annual)
- ₹276.4 Cr
- Net profit (annual)
- ₹28.55 Cr
- P/E (TTM)
- 20.2×Sector 51.1×
- Promoter holding
- 47.20%-2.41% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chandan Healthcare Ltd
All →Chandan Healthcare Annual General Meeting
Chandan Healthcare calls an EGM on 20 November 2026 to approve related party transactions, including director guarantees. E-voting runs 17 to 19 November 2026.
Chandan Healthcare Results Update
Chandan Healthcare's Q2 FY2027 revenue from diagnostics grew 46.66% YoY to Rs. 56.38 Crore, while its franchise network expanded to 685 locations.
- franchise expansion
- 410.0 franchises
Chandan Healthcare Management Change
Mr. Vinod Jain has resigned from his position as Independent Director of Chandan Healthcare Limited, effective October 5, 2026, due to other professional commitments.
Chandan Healthcare Annual General Meeting
Chandan Healthcare Limited held its 23rd Annual General Meeting on September 30, 2026. The meeting covered routine business, including financial adoption and board appointments.
Chandan Healthcare Capital Structure Change
Chandan Healthcare allotted 6,50,000 equity shares upon conversion of warrants for ₹15.21 Crore consideration.
- Value
- ₹15.21 Cr
Chandan Healthcare Capacity Expansion
Chandan Healthcare scaled its diagnostic franchise network to 500+ centres, reaching a total of 568+ centres. It targets 1,000 centres by FY27-end and 3,000 in two years.
- diagnostic franchise collection centres
- 500 franchise centres
Other debt & borrowing announcements
All →Spandana Sphoorty Financial Debt & Borrowing: ₹0.49 Cr
Spandana paid ₹0.49 Crore of quarterly interest on its secured NCDs on 27 October 2026. The coupon rate is 10.75% on a ₹50 Crore issue.
- Value
- ₹0.49 Cr
Mangalam Worldwide Debt & Borrowing: ₹1.14 Cr
Mangalam Worldwide paid Rs. 1.14 Crore interest on its NCDs (ISIN INE0JYY07026) on 28 October 2026, net of TDS. The company confirmed timely payment under Regulation 57.
- Value
- ₹1.14 Cr
Lloyds Metals & Energy Debt & Borrowing: ₹12,370 Cr
Lloyds Metals allotted 1,300 debt securities worth about ₹12,370 Crore on 29 October 2026. Three-year coupon is SOFR plus 450 bps, secured by Virtus Lloyds share pledges.
- Value
- ₹12,370 Cr
- Execution
- 3 years
Lloyds Metals & Energy Debt & Borrowing: ₹1,235 Cr
Lloyds Metals' committee approved terms for USD 130 million senior secured notes, about Rs.1,235 Crore. The notes mature in October 2029 at SOFR plus 450 bps.
- Value
- ₹1,235 Cr
Arisinfra Solutions Debt & Borrowing: ₹3.9 Cr
Arisinfra guaranteed Rs 3.90 Crore for subsidiary White Roots Infra Trading's SBI credit facility. The guarantee is contingent, with no current impact on the listed company.
- Value
- ₹3.90 Cr
Sammaan Capital Debt & Borrowing: ₹0.06 Cr
Sammaan Capital certified timely monthly interest payments on two listed secured NCD series, totalling about ₹5.73 lakh. The filing confirms servicing of existing debt rather than new borrowing.
- Value
- ₹0.06 Cr